We study an individual patient's tumor vis generation and analysis of full genome data to identify specific biological drivers of your disease, and treatments, or clinical trials, that may be address these drivers. Our focus is on cancers where validated treatment options have a low chance of success (e.g., <30%) - regardless of cancer type - and where an uncoventional treatment or a trial might be appropriate, if strongly supported by scientific analysis. We work in partnership with the patient's oncologist to ensure that our results are interpreted in the patient's entire medical context. The decision to recommend a treatment approach to the patient remains, as always, in the hands of the physician. Please visit our website at http://www.genekey.com and feel free to contact me if you are - an interested patient - an interested physician, hospital, researcher, or payor - an entrepreneur/general manager interested in joining us - a senior genomic scientist, with both wet lab and 10+ years computational experience (including with network analysis) - an investor interested in learning more